Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed

Circulation. 1999 Mar 16;99(10):1355-62. doi: 10.1161/01.cir.99.10.1355.

Abstract

Background: Secoisolariciresinol diglucoside (SDG) is a plant lignan isolated from flaxseed. Lignans are platelet-activating factor-receptor antagonists that would inhibit the production of oxygen radicals by polymorphonuclear leukocytes. SDG is an antioxidant. Antioxidants studied thus far are known to reduce hypercholesterolemic atherosclerosis. The objective of this study was to determine the effect of SDG on various blood lipid and aortic tissue oxidative stress parameters and on the development of atherosclerosis in rabbits fed a high-cholesterol diet.

Methods and results: Rabbits were assigned to 4 groups: group 1, control; group 2, SDG control (15 mg. kg body wt-1. d-1 PO); group 3, 1% cholesterol diet; and group 4, same as group 3 but with added SDG (15 mg. kg body wt-1. d-1 PO). Blood samples were collected before (time 0) and after 4 and 8 weeks of experimental diets for measurement of serum triglycerides, total cholesterol (TC), and LDL, HDL, and VLDL cholesterol (LDL-C, HDL-C, and VLDL-C). The aorta was removed at the end of the protocol for assessment of atherosclerotic plaques; malondialdehyde, an aortic tissue lipid peroxidation product; and aortic tissue chemiluminescence, a marker for antioxidant reserve. Serum TC, LDL-C, and the ratios LDL-C/HDL-C and TC/HDL-C increased in groups 3 and 4 compared with time 0, the increase being smaller in group 4 than in group 3. Serum HDL-C decreased in group 3 and increased in group 4 compared with time 0, but changes were lower in group 3 than in group 4. SDG reduced TC and LDL-C by 33% and 35%, respectively, at week 8 but increased HDL-C significantly, by>140%, as early as week 4. It also decreased TC/LDL-C and LDL-C/HDL-C ratios by approximately 64%. There was an increase in aortic malondialdehyde and chemiluminescence in group 3, and they were lower in group 4 than in group 3. SDG reduced hypercholesterolemic atherosclerosis by 73%.

Conclusions: These results suggest that SDG reduced hypercholesterolemic atherosclerosis and that this effect was associated with a decrease in serum cholesterol, LDL-C, and lipid peroxidation product and an increase in HDL-C and antioxidant reserve.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aortic Diseases / drug therapy
  • Aortic Diseases / etiology
  • Aortic Diseases / pathology
  • Arteriosclerosis / drug therapy*
  • Arteriosclerosis / etiology
  • Arteriosclerosis / pathology
  • Body Weight / drug effects
  • Butylene Glycols / isolation & purification
  • Butylene Glycols / pharmacology
  • Butylene Glycols / therapeutic use*
  • Cholesterol / blood*
  • Cholesterol, LDL / blood
  • Diet, Atherogenic
  • Glucosides / isolation & purification
  • Glucosides / pharmacology
  • Glucosides / therapeutic use*
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / drug therapy*
  • Lipid Peroxidation
  • Lipoproteins / blood
  • Luminescent Measurements
  • Malondialdehyde / analysis
  • Rabbits
  • Seeds / chemistry
  • Triglycerides / blood

Substances

  • Butylene Glycols
  • Cholesterol, LDL
  • Glucosides
  • Lipoproteins
  • Triglycerides
  • Malondialdehyde
  • Cholesterol
  • secoisolariciresinol diglucoside